Literature DB >> 2589201

Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease.

H A Rockman1, C Juneau, K Chatterjee, J L Rouleau.   

Abstract

Clinical, hemodynamic and neurohumoral variables in 238 patients with chronic congestive heart failure (CHF) secondary to coronary artery disease were analyzed to determine potential predictors of mortality in a large population and to allow analysis according to mode of death (sudden or low output death). All variables were assessed before initiation of treatment with vasodilators (converting enzyme inhibitors, direct acting vasodilators) or with the nonglycoside, noncatecholamine class of inotropic agents. Survival outcome was determined as alive, sudden death or low output death. When all variables except ejection fraction were analyzed by Cox multiple regression analysis, the most important independent predictor of all deaths was the baseline plasma renin activity (p less than 0.001). When subdivided by cause of cardiovascular death, baseline plasma renin activity was retained as the most important determinant of low output death (p less than 0.001), whereas baseline left ventricular stroke work index (p less than 0.001), pulmonary capillary wedge pressure (p less than 0.002) and absence of sinus rhythm (p less than 0.006) were the most powerful independent predictors of sudden death. Plasma norepinephrine was markedly elevated in the group dying of low output, but only modestly elevated in the group of survivors and the group dying suddenly. However, baseline norepinephrine was not found to be an important independent predictor of mortality in any of the subgroups. Plasma renin activity, but not plasma norepinephrine, is a powerful independent prognostic determinant of mortality in this group of patients with CHF.

Entities:  

Mesh:

Year:  1989        PMID: 2589201     DOI: 10.1016/0002-9149(89)90579-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Plasma catecholamines: follow-up on 10-year study in health and cardiovascular disease.

Authors:  P Prikryl; G Cornélissen; K Otsuka; F Halberg
Journal:  Biomed Pharmacother       Date:  2005-10       Impact factor: 6.529

2.  Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.

Authors:  F X Kleber; L Niemöller; W Doering
Journal:  Br Heart J       Date:  1992-04

3.  Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance.

Authors:  Francisco Leyva; Paul W X Foley; Shajil Chalil; Karim Ratib; Russell E A Smith; Frits Prinzen; Angelo Auricchio
Journal:  J Cardiovasc Magn Reson       Date:  2011-06-13       Impact factor: 5.364

4.  Cardiac Resynchronization Therapy Using Quadripolar Versus Non-Quadripolar Left Ventricular Leads Programmed to Biventricular Pacing With Single-Site Left Ventricular Pacing: Impact on Survival and Heart Failure Hospitalization.

Authors:  Francisco Leyva; Abbasin Zegard; Tian Qiu; Edmund Acquaye; Gaetano Ferrante; Jamie Walton; Howard Marshall
Journal:  J Am Heart Assoc       Date:  2017-10-17       Impact factor: 5.501

5.  Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.

Authors:  Francisco Leyva; Abbasin Zegard; Fraz Umar; Robin James Taylor; Edmund Acquaye; Christopher Gubran; Shajil Chalil; Kiran Patel; Jonathan Panting; Howard Marshall; Tian Qiu
Journal:  Europace       Date:  2018-11-01       Impact factor: 5.214

6.  Long-Term Outcomes of Cardiac Resynchronization Therapy Using Apical Versus Nonapical Left Ventricular Pacing.

Authors:  Francisco Leyva; Abbasin Zegard; Robin J Taylor; Paul W X Foley; Fraz Umar; Kiran Patel; Jonathan Panting; Peter van Dam; Frits W Prinzen; Howard Marshall; Tian Qiu
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

7.  Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias.

Authors:  Osita Okafor; Abbasin Zegard; Peter van Dam; Berthold Stegemann; Tian Qiu; Howard Marshall; Francisco Leyva
Journal:  J Am Heart Assoc       Date:  2019-10-28       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.